{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:20:12Z","timestamp":1790914812305,"version":"4.1.0"},"reference-count":50,"publisher":"American Society of Hematology","issue":"7","license":[{"start":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T00:00:00Z","timestamp":1684713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Systematic studies of germ line genetic predisposition to myeloid neoplasms in adult patients are still limited. In this work, we performed germ line and somatic targeted sequencing in a cohort of adult patients with hypoplastic bone marrow (BM) to study germ line predisposition variants and their clinical correlates. The study population included 402 consecutive adult patients investigated for unexplained cytopenia and reduced age-adjusted BM cellularity. Germ line mutation analysis was performed using a panel of 60 genes, and variants were interpreted per the American College of Medical Genetics and Genomics\/Association for Molecular Pathology guidelines; somatic mutation analysis was performed using a panel of 54 genes. Of the 402 patients, 27 (6.7%) carried germ line variants that caused a predisposition syndrome\/disorder. The most frequent disorders were DDX41-associated predisposition, Fanconi anemia, GATA2-deficiency syndrome, severe congenital neutropenia, RASopathy, and Diamond-Blackfan anemia. Eighteen of 27 patients (67%) with causative germ line genotype were diagnosed with myeloid neoplasm, and the remaining with cytopenia of undetermined significance. Patients with a predisposition syndrome\/disorder were younger than the remaining patients and had a higher risk of severe or multiple cytopenias and advanced myeloid malignancy. In patients with myeloid neoplasm, causative germ line mutations were associated with increased risk of progression into acute myeloid leukemia. Family or personal history of cancer did not show significant association with a predisposition syndrome\/disorder. The findings of this study unveil the spectrum, clinical expressivity, and prevalence of germ line predisposition mutations in an unselected cohort of adult patients with cytopenia and hypoplastic BM.<\/jats:p>","DOI":"10.1182\/blood.2022019304","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T21:33:57Z","timestamp":1684791237000},"page":"643-657","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":21,"title":["Prevalence and clinical expression of germ line predisposition to myeloid neoplasms in adults with marrow hypocellularity"],"prefix":"10.1182","volume":"142","author":[{"given":"Elisabetta","family":"Molteni","sequence":"first","affiliation":[{"name":"1Department of Molecular Medicine, University of Pavia, Pavia, Italy"},{"name":"2Department of Hematology Oncology, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Bono","sequence":"additional","affiliation":[{"name":"1Department of Molecular Medicine, University of Pavia, Pavia, Italy"},{"name":"2Department of Hematology Oncology, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4039-3756","authenticated-orcid":false,"given":"Anna","family":"Gall\u00ec","sequence":"additional","affiliation":[{"name":"2Department of Hematology Oncology, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Elena","sequence":"additional","affiliation":[{"name":"2Department of Hematology Oncology, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Ferrari","sequence":"additional","affiliation":[{"name":"1Department of Molecular Medicine, University of Pavia, Pavia, Italy"},{"name":"2Department of Hematology Oncology, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Fiorelli","sequence":"additional","affiliation":[{"name":"1Department of Molecular Medicine, University of Pavia, Pavia, Italy"},{"name":"2Department of Hematology Oncology, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Pozzi","sequence":"additional","affiliation":[{"name":"1Department of Molecular Medicine, University of Pavia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0130-915X","authenticated-orcid":false,"given":"Virginia Valeria","family":"Ferretti","sequence":"additional","affiliation":[{"name":"3Unit of Clinical Epidemiology and Biometrics, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Sarchi","sequence":"additional","affiliation":[{"name":"1Department of Molecular Medicine, University of Pavia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1631-9000","authenticated-orcid":false,"given":"Ettore","family":"Rizzo","sequence":"additional","affiliation":[{"name":"4enGenome SRL, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Camilotto","sequence":"additional","affiliation":[{"name":"1Department of Molecular Medicine, University of Pavia, Pavia, Italy"},{"name":"2Department of Hematology Oncology, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4932-3527","authenticated-orcid":false,"given":"Emanuela","family":"Boveri","sequence":"additional","affiliation":[{"name":"5Department of Pathology, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6984-8817","authenticated-orcid":false,"given":"Mario","family":"Cazzola","sequence":"additional","affiliation":[{"name":"1Department of Molecular Medicine, University of Pavia, Pavia, Italy"},{"name":"2Department of Hematology Oncology, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1460-1611","authenticated-orcid":false,"given":"Luca","family":"Malcovati","sequence":"additional","affiliation":[{"name":"1Department of Molecular Medicine, University of Pavia, Pavia, Italy"},{"name":"2Department of Hematology Oncology, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2023081715241521800_bib1","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The\u00a02016 revision to the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"4","key":"2023081715241521800_bib2","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2017-02-735290","article-title":"Genetic predisposition to hematologic malignancies: management and surveillance","volume":"130","author":"Godley","year":"2017","journal-title":"Blood"},{"issue":"11","key":"2023081715241521800_bib3","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"7","key":"2023081715241521800_bib4","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"3","key":"2023081715241521800_bib5","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/leu.2016.342","article-title":"Mutational landscape in children with myelodysplastic syndromes is distinct from adults: specific somatic drivers and novel germline variants","volume":"31","author":"Pastor","year":"2017","journal-title":"Leukemia"},{"issue":"11","key":"2023081715241521800_bib6","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood-2015-09-669937","article-title":"Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents","volume":"127","author":"Wlodarski","year":"2016","journal-title":"Blood"},{"issue":"5","key":"2023081715241521800_bib7","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/leu.2017.28","article-title":"Clinical utility of gene panel-based testing for hereditary myelodysplastic syndrome\/acute leukemia predisposition syndromes","volume":"31","author":"Guidugli","year":"2017","journal-title":"Leukemia"},{"issue":"2","key":"2023081715241521800_bib8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1053\/j.seminhematol.2016.11.003","article-title":"Recognition of familial myeloid neoplasia in adults","volume":"54","author":"Brown","year":"2017","journal-title":"Semin Hematol"},{"issue":"22","key":"2023081715241521800_bib9","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1182\/blood.2020006910","article-title":"Identifying potential germline variants from sequencing hematopoietic malignancies","volume":"136","author":"Kraft","year":"2020","journal-title":"Blood"},{"issue":"14","key":"2023081715241521800_bib10","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1182\/blood-2016-05-670240","article-title":"How I diagnose and manage individuals at risk for inherited myeloid malignancies","volume":"128","author":"The University of Chicago Hematopoietic Malignancies Cancer Risk Team","year":"2016","journal-title":"Blood"},{"issue":"6","key":"2023081715241521800_bib11","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1056\/NEJMoa1611604","article-title":"Prognostic mutations in myelodysplastic syndrome after stem-cell transplantation","volume":"376","author":"Lindsley","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"2023081715241521800_bib12","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1182\/blood.2021011075","article-title":"The clinical and functional effects of TERT variants in myelodysplastic syndrome","volume":"138","author":"Reilly","year":"2021","journal-title":"Blood"},{"issue":"24","key":"2023081715241521800_bib13","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1182\/blood.2022015790","article-title":"Germline predisposition variants occur in myelodysplastic syndrome patients of all ages","volume":"140","author":"Feurstein","year":"2022","journal-title":"Blood"},{"issue":"12","key":"2023081715241521800_bib14","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1038\/s41375-022-01729-4","article-title":"Significance of hereditary gene alterations for the pathogenesis of adult bone marrow failure versus myeloid neoplasia","volume":"36","author":"Kubota","year":"2022","journal-title":"Leukemia"},{"issue":"8","key":"2023081715241521800_bib15","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1038\/s41375-021-01137-0","article-title":"Germline variants drive myelodysplastic syndrome in young adults","volume":"35","author":"Feurstein","year":"2021","journal-title":"Leukemia"},{"issue":"7","key":"2023081715241521800_bib16","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1182\/blood-2017-09-806489","article-title":"A\u00a0landscape of germ line mutations in a cohort of inherited bone marrow failure patients","volume":"131","author":"Bluteau","year":"2018","journal-title":"Blood"},{"issue":"17","key":"2023081715241521800_bib17","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1182\/blood.2019000909","article-title":"Germline DDX41 mutations define a significant entity within adult MDS\/AML patients","volume":"134","author":"Sebert","year":"2019","journal-title":"Blood"},{"issue":"8","key":"2023081715241521800_bib18","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1182\/blood-2015-10-676098","article-title":"Novel germ line DDX41 mutations define families with a lower age of MDS\/AML onset and lymphoid malignancies","volume":"127","author":"Lewinsohn","year":"2016","journal-title":"Blood"},{"issue":"5","key":"2023081715241521800_bib19","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.ccell.2015.03.017","article-title":"Inherited and somatic defects in DDX41 in myeloid neoplasms","volume":"27","author":"Polprasert","year":"2015","journal-title":"Cancer Cell"},{"issue":"7","key":"2023081715241521800_bib20","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1182\/blood.2021015135","article-title":"The genetic landscape of germline DDX41 variants predisposing to myeloid neoplasms","volume":"140","author":"Li","year":"2022","journal-title":"Blood"},{"issue":"5","key":"2023081715241521800_bib21","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1182\/blood.2022018221","article-title":"Germ line DDX41 mutations define a unique subtype of myeloid neoplasms","volume":"141","author":"Makishima","year":"2023","journal-title":"Blood"},{"issue":"10","key":"2023081715241521800_bib22","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1038\/s41375-019-0457-1","article-title":"Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome","volume":"33","author":"Bono","year":"2019","journal-title":"Leukemia"},{"issue":"17","key":"2023081715241521800_bib23","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1182\/blood-2013-03-492884","article-title":"Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet","volume":"122","author":"Malcovati","year":"2013","journal-title":"Blood"},{"issue":"6","key":"2023081715241521800_bib24","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1097\/HS9.0000000000000150","article-title":"Diagnosis and treatment of chronic myelomonocytic leukemias in adults: recommendations from the European Hematology Association and the European LeukemiaNet","volume":"2","author":"Itzykson","year":"2018","journal-title":"Hemasphere"},{"issue":"21","key":"2023081715241521800_bib25","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1182\/blood.2022015853","article-title":"Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia","volume":"140","author":"Duncavage","year":"2022","journal-title":"Blood"},{"issue":"8","key":"2023081715241521800_bib26","first-page":"1128","article-title":"European consensus on grading bone marrow fibrosis and assessment of cellularity","volume":"90","author":"Thiele","year":"2005","journal-title":"Haematologica"},{"issue":"43","key":"2023081715241521800_bib27","doi-asserted-by":"crossref","first-page":"73483","DOI":"10.18632\/oncotarget.19008","article-title":"Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions","volume":"8","author":"Valent","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"2023081715241521800_bib28","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/asheducation-2015.1.299","article-title":"The shadowlands of MDS: idiopathic cytopenias of undetermined significance (ICUS) and clonal hematopoiesis of indeterminate potential (CHIP)","volume":"2015","author":"Malcovati","year":"2015","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"21","key":"2023081715241521800_bib29","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1182\/blood-2018-01-827881","article-title":"Germ line tissues for optimal detection of somatic variants in myelodysplastic syndromes","volume":"131","author":"Padron","year":"2018","journal-title":"Blood"},{"issue":"5","key":"2023081715241521800_bib30","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"20","key":"2023081715241521800_bib31","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/bloodadvances.2019000644","article-title":"ClinGen myeloid malignancy variant curation expert panel recommendations for germline RUNX1 variants","volume":"3","author":"Luo","year":"2019","journal-title":"Blood Adv"},{"issue":"25","key":"2023081715241521800_bib32","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1182\/blood-2017-01-763425","article-title":"Clinical significance of somatic mutation in unexplained blood cytopenia","volume":"129","author":"Malcovati","year":"2017","journal-title":"Blood"},{"issue":"11","key":"2023081715241521800_bib33","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood.2021011323","article-title":"Relationship between clone metrics and clinical outcome in clonal cytopenia","volume":"138","author":"Galli","year":"2021","journal-title":"Blood"},{"issue":"20","key":"2023081715241521800_bib34","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1182\/bloodadvances.2020002013","article-title":"Heterozygous germ line CSF3R variants as risk alleles for development of hematologic malignancies","volume":"4","author":"Trottier","year":"2020","journal-title":"Blood Adv"},{"issue":"8","key":"2023081715241521800_bib35","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1182\/blood-2003-09-3138","article-title":"Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia","volume":"103","author":"Wagner","year":"2004","journal-title":"Blood"},{"issue":"suppl 1","key":"2023081715241521800_bib36","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1590\/1678-4685-gmb-2018-0104","article-title":"Reviewing the characteristics of BRCA and PALB2-related cancers in the precision medicine era","volume":"42","author":"Macedo","year":"2019","journal-title":"Genet Mol Biol"},{"issue":"11","key":"2023081715241521800_bib37","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nrg3031","article-title":"Exome sequencing as a tool for Mendelian disease gene discovery","volume":"12","author":"Bamshad","year":"2011","journal-title":"Nat Rev Genet"},{"issue":"21","key":"2023081715241521800_bib38","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1182\/blood-2017-05-787390","article-title":"Germline loss-of-function SAMD9 and SAMD9L alterations in adult myelodysplastic syndromes","volume":"132","author":"Nagata","year":"2018","journal-title":"Blood"},{"issue":"1","key":"2023081715241521800_bib39","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/s41467-020-14829-5","article-title":"The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants","volume":"11","author":"Rio-Machin","year":"2020","journal-title":"Nat Commun"},{"issue":"9","key":"2023081715241521800_bib40","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1182\/blood-2004-06-2094","article-title":"A\u00a0functional single-nucleotide polymorphism of the G-CSF receptor gene predisposes individuals to high-risk myelodysplastic syndrome","volume":"105","author":"Wolfler","year":"2005","journal-title":"Blood"},{"key":"2023081715241521800_bib41","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fonc.2014.00093","article-title":"Granulocyte colony-stimulating factor receptor mutations in myeloid malignancy","volume":"4","author":"Liongue","year":"2014","journal-title":"Front Oncol"},{"issue":"31","key":"2023081715241521800_bib42","doi-asserted-by":"crossref","first-page":"11444","DOI":"10.1073\/pnas.0404241101","article-title":"Mpl Baltimore: a thrombopoietin receptor polymorphism associated with thrombocytosis","volume":"101","author":"Moliterno","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"21","key":"2023081715241521800_bib43","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/bloodadvances.2016002915","article-title":"Gene editing rescue of a novel MPL mutant associated with congenital amegakaryocytic thrombocytopenia","volume":"1","author":"Cleyrat","year":"2017","journal-title":"Blood Adv"},{"issue":"5","key":"2023081715241521800_bib44","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/s41375-022-01515-2","article-title":"Acquired somatic variants in inherited myeloid malignancies","volume":"36","author":"Armes","year":"2022","journal-title":"Leukemia"},{"issue":"15","key":"2023081715241521800_bib45","doi-asserted-by":"crossref","first-page":"e2014967118","DOI":"10.1073\/pnas.2014967118","article-title":"Alternative splicing redefines landscape of commonly mutated genes in acute myeloid leukemia","volume":"118","author":"Rivera","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2023081715241521800_bib46","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1261\/rna.079277.122","article-title":"A\u00a0dual role for the RNA helicase DHX34 in NMD and pre-mRNA splicing and its function in hematopoietic differentiation","volume":"28","author":"Hug","year":"2022","journal-title":"RNA"},{"issue":"11","key":"2023081715241521800_bib47","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/gim.2018.3","article-title":"ClinGen's RASopathy Expert Panel consensus methods for variant interpretation","volume":"20","author":"Gelb","year":"2018","journal-title":"Genet Med"},{"issue":"3","key":"2023081715241521800_bib48","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/humu.24152","article-title":"Specifications of the ACMG\/AMP variant interpretation guidelines for germline TP53\u00a0variants","volume":"42","author":"Fortuno","year":"2021","journal-title":"Hum Mutat"},{"issue":"10","key":"2023081715241521800_bib49","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1182\/blood.2021012304","article-title":"The journey of a thousand miles begins with 1 step","volume":"138","author":"Malcovati","year":"2021","journal-title":"Blood"},{"issue":"11","key":"2023081715241521800_bib50","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1038\/s41375-021-01246-w","article-title":"Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer","volume":"35","author":"Singhal","year":"2021","journal-title":"Leukemia"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/142\/7\/643\/2072181\/blood_bld-2022-019304-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/142\/7\/643\/2072181\/blood_bld-2022-019304-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T15:27:02Z","timestamp":1692286022000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/142\/7\/643\/495977\/Prevalence-and-clinical-expression-of-germ-line"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,17]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,8,17]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2022019304","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,17]]}}}